7 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators.
Vanderbilt University
Discovery of 'molecular switches' within a GIRK activator scaffold that afford selective GIRK inhibitors.
Northwest Agriculture & Forestry University
Discovery of a brain-sparing GIRK1/4 inhibitor for pharmacological cardioversion of atrial fibrillation.
Novartis Institutes For Biomedical Research
Discovery, synthesis and biological characterization of a series of
University of Nebraska
Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators.
University of Nebraska Medical Center
Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents.
Astrazeneca